Literature DB >> 21963389

The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: a randomized, placebo-controlled study.

A Roessler1, S D Forssten, M Glei, A C Ouwehand, G Jahreis.   

Abstract

BACKGROUND: Colonic microbiota is involved in the etiology of colon cancer according to several reports. Studies also indicate that the microbiota differs between atopic patients and healthy subjects.
OBJECTIVE: To evaluate whether a probiotic mix containing Lactobacillus paracasei Lpc-37, Lactobacillus acidophilus 74-2, and Bifidobacterium animalis subsp. lactis DGCC 420 can affect the microbiota and its genotoxic activity in healthy subjects and patients with atopic dermatitis (AD).
METHODS: A placebo-controlled cross-over study was conducted. Fifteen healthy adults and 15 adult AD patients consumed 2×100 ml/d of either a probiotic or a placebo drink for 8 weeks followed by a wash out period of 2 weeks before crossing the intervention. Faecal water was isolated from stool samples collected at the end of each period. HT29c19a cells incubated with faecal water were measured for DNA damage using single-cell gel electrophoresis ("comet assay"). Bacterial species were determined by qPCR and concentrations of short-chain fatty acids were measured by means of gas chromatography.
RESULTS: Probiotic supplementation resulted in a significant increase in lactobacilli, whereas numbers of Bifidobacteria and Bacteroidetes remained unchanged. Clostridium perfringens cluster I-II was significantly reduced in healthy subjects. Genotoxic potential (expressed as tail intensity) of faecal water, was not affected. However, tail intensity decreased significantly in the probiotic period compared to placebo (23.5 vs. 16.7%) in AD patients. Although faecal concentrations of short-chain fatty acids were not affected, faecal pH was significantly reduced (7.0 vs. 6.6) in AD patients after probiotics.
CONCLUSION: The results indicate that probiotics lower the genotoxic potential of faecal water in AD patients. The faecal C. perfringens cluster I-II levels remained unaffected suggesting either a change in their activity, or the fact that other bacterial species are responsible for the reduced genotoxic activity of faecal water.
Copyright © 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21963389     DOI: 10.1016/j.clnu.2011.08.012

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  13 in total

1.  Bifidobacterium animalis subsp. lactis 420 mitigates the pathological impact of myocardial infarction in the mouse.

Authors:  C A Danilo; E Constantopoulos; L A McKee; H Chen; J A Regan; Y Lipovka; S Lahtinen; L K Stenman; T-V V Nguyen; K P Doyle; M J Slepian; Z I Khalpey; J P Konhilas
Journal:  Benef Microbes       Date:  2017-04-14       Impact factor: 4.205

Review 2.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

3.  Complete genome sequences of probiotic strains Bifidobacterium animalis subsp. lactis B420 and Bi-07.

Authors:  Buffy Stahl; Rodolphe Barrangou
Journal:  J Bacteriol       Date:  2012-08       Impact factor: 3.490

4.  The Difference of Gut Microbiota and Their Correlations With Urinary Organic Acids Between Autistic Children With and Without Atopic Dermatitis.

Authors:  Ru-Ping Hong; Yue-Ying Hou; Xin-Jie Xu; Ji-Dong Lang; Yun-Feng Jin; Xiao-Feng Zeng; Xuan Zhang; Geng Tian; Xin You
Journal:  Front Cell Infect Microbiol       Date:  2022-06-21       Impact factor: 6.073

Review 5.  Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated Diseases.

Authors:  Eva Maria Sturm; Eva Knuplez; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

6.  Metabolic diseases and pro- and prebiotics: Mechanistic insights.

Authors:  Yukiko K Nakamura; Stanley T Omaye
Journal:  Nutr Metab (Lond)       Date:  2012-06-19       Impact factor: 4.169

7.  Effects of probiotics on the prevention of atopic dermatitis.

Authors:  Nam Yeun Kim; Geun Eog Ji
Journal:  Korean J Pediatr       Date:  2012-06-21

Review 8.  Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review.

Authors:  Lynne V McFarland
Journal:  BMJ Open       Date:  2014-08-25       Impact factor: 2.692

9.  Probiotics for treating eczema.

Authors:  Areti Makrgeorgou; Jo Leonardi-Bee; Fiona J Bath-Hextall; Dedee F Murrell; Mimi Lk Tang; Amanda Roberts; Robert J Boyle
Journal:  Cochrane Database Syst Rev       Date:  2018-11-21

10.  Effects of legume kernel fibres and citrus fibre on putative risk factors for colorectal cancer: a randomised, double-blind, crossover human intervention trial.

Authors:  Anita Fechner; Katrin Fenske; Gerhard Jahreis
Journal:  Nutr J       Date:  2013-07-16       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.